Navigation Links
Drug might prevent Prostate Cancer Spread

A drug commonly used to prevent bone loss may also help prevent prostate cancer from spreading. A new study indicates oral sodium // clodronate may slow the spread of cancer to the bone and reduce the risk of death. This is a drug commonly used to prevent bone loss.

Estimates show prostate cancer spreads to the bone in about 85 percent of men. The researchers recruited 311 men who were being given hormone therapy for bone metastases. The patients who received oral sodium clodronate had a 21-percent reduction in risk of bone metastases and a 20-percent reduction in their risk of death. The researchers write, “Our results suggest that men treated with the bisphosphonate sodium clodronate have longer symptomatic bone progression-free survival times than men treated with placebo.”

More than 70 percent of the men who took the medication also reported a significant number of side effects. The physicians report side effects lessened when the dosage was adjusted. The study investigators say these findings are still lacking. They used a small group of patients and say the oral medication used is difficult for the body to absorb. A different form of sodium clodronate may have a different outcome.

Researchers say, this study is important and gives doctors new information to consider when treating newly diagnosed patients.
'"/>




Page: 1

Related medicine news :

1. Suicide might be inherited
2. Cleanliness might lead to Asthma
3. Stroke risk might be linked to antibody
4. Change in walking might indicate Dementia
5. Drug might prevent Prostate Cancer Spread
6. Diet might just have an Effect on Breast Cancer
7. Chlorine might be a cause for Asthma
8. Pill might be able to reduce the damage loud noise does to your hearing
9. Women might be at increased risk of HIV during pregnancy
10. Older generation might pose a threat to increase the NHS budget
11. Cabbage, cauliflower might contribute to cancer prevention
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The MBI “Hall of Fame” recognizes the ... acts have had a significant impact on the careers of all others involved. ... Inc. was inducted into the MBI’s Hall of Fame. The induction took place during ...
(Date:3/23/2017)... OH (PRWEB) , ... March ... ... insurance and financial services firm serving the families and businesses of the ... community enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based ...
(Date:3/23/2017)... Atlanta, GA (PRWEB) , ... March 23, 2017 ... ... announced the release of SmartBen NOW, an innovative mobile app and centralized benefits ... gather and present critical information securely from multiple locations. For the first time, ...
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, ... ... Series A funding investment in Los Angeles based healthcare technology company California Healthcom ... group’s portfolio into the US, and healthcare arena. With headquarters in California, CHG ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 CENTRO DE ... article 157, paragraph 4 of Law 6,404/76 and Instruction ... hereby informs its shareholders and the market in general ... its subsidiary Centro de Diagnosticos por Imagem Ltda. (" ... 100% interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " ...
(Date:3/23/2017)... 23, 2017  The goal of the pilot ... and track prescription drugs as they are distributed in ... to requirements from US FDA to better protect consumers ... medicines. Blockchain startup Chronicled, which links ... and blockchain technology and recently raised $6.25M, and the ...
(Date:3/23/2017)... N.J. , March 23, 2017 /PRNewswire/ ... company, announced a major milestone today.  Following ... with the U.S. Food and Drug Administration ... clear clinical and regulatory path forward to ... CPI-613, in patients with acute myeloid leukemia ...
Breaking Medicine Technology: